Although several targets of Hh‐GLI2 pathway have been reported,10, 11 identification of bona fide effectors downstream of GLI2 would not only deepen insights of the oncogenic mechanisms of this pathway, but also provide novel actionable target for Hh‐driven cancer. Here, GLI2 is linked to cancer.